Utilization of Transthoracic Echocardiography and Biochemical Markers in Detecting Cardiomyopathy in Fabry Disease
TTE and biochemical trends highlight the gradual and insidious nature of FD progression, and stress the importance of considering multiparametric endpoints, including GLS, atrial function, and biomarkers, when assessing outcome in FD.
Authors
- Tarekegn Geberhiwot (ORCID: https://orcid.org/0000-0002-3629-2338)
- S. Thompson (ORCID: https://orcid.org/0000-0002-8645-5529)
- Ashwin Roy (ORCID: https://orcid.org/0000-0003-4600-2733)
- David Oxborough (ORCID: https://orcid.org/0000-0002-1334-3286)
- Richard P. Steeds (ORCID: https://orcid.org/0000-0001-5687-2535)
- Max J. Cumberland (ORCID: https://orcid.org/0009-0002-7124-5390)
- Kyaw Zaw Win (ORCID: https://orcid.org/0000-0002-8553-5914)
- James Hodson (ORCID: https://orcid.org/0000-0003-3487-0090)
- Antonio Ochoa‐Ferraro (ORCID: https://orcid.org/0000-0003-0406-1436)
- Amor Mia Alvior (ORCID: https://orcid.org/0009-0008-7994-7614)
Institutions
- University Hospitals Birmingham NHS Foundation Trust (GB)
- Westmead Institute (AU)
- Liverpool John Moores University (GB)
- University of Birmingham (GB)
Publication Details
- Journal
- CJC Open
- Published
- 2025-01-23
- DOI
- https://doi.org/10.1016/j.cjco.2025.01.017
- Citations
- 2
- Primary Topic
- Lysosomal Storage Disorders Research
- Type
- article
- Field-Weighted Citation Impact
- 2.33